Article info
How to do it
Advising patients seeking stem cell interventions for multiple sclerosis
- Correspondence to Dr Claire M Rice, Clinical Neurosciences, Translational Health Sciences, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol, BS10 5NB, UK; C.M.Rice{at}bristol.ac.uk
Citation
Advising patients seeking stem cell interventions for multiple sclerosis
Publication history
- Accepted May 7, 2018
- First published May 30, 2018.
Online issue publication
November 16, 2018
Article Versions
- Previous version (30 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
- Autologous haematopoietic stem cell transplantation for neurological diseases
- Haematopoietic stem cell transplantation in systemic sclerosis
- Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study
- Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP
- Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis
- Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
- Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation
- Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why?
- Current outlook of cardiac stem cell therapy towards a clinical application